John David Finley - 11 Mar 2024 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
CEO, CFO, Director, Director
Signature
/s/ JD Finley
Issuer symbol
PALI
Transactions as of
11 Mar 2024
Net transactions value
$0
Form type
4
Filing time
12 Mar 2024, 18:29:18 UTC
Previous filing
07 Feb 2024
Next filing
08 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PALI Common Stock, par value $0.01 Options Exercise $0 +5,558 +6.1% $0.000000 96,849 11 Mar 2024 Direct F1
holding PALI Common Stock, par value $0.01 777 11 Mar 2024 By FCW Investments, LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Options Exercise -5,558 -10% 50,025 11 Mar 2024 Common Stock 5,558 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023.
F2 Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.
F3 Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F4 This restricted stock unit was granted on June 11, 2023, and 5,558 restricted stock units subject to the award vested on March 11, 2024, and an additional 50,025 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.